{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06502483",
            "orgStudyIdInfo": {
                "id": "24-147"
            },
            "organization": {
                "fullName": "Dana-Farber Cancer Institute",
                "class": "OTHER"
            },
            "briefTitle": "PRISM for Depression and Anxiety in Young Adults With Cancer",
            "officialTitle": "Treatment Development Study of the Promoting Resilience in Stress Management (PRISM) Intervention for Depression and Anxiety in Young Adults With Cancer",
            "acronym": "PRISM",
            "therapeuticArea": [
                "Mental Health",
                "Oncology and Hematology",
                "Other"
            ],
            "study": "prism-for-depression-and-anxiety-in-young-adults-with-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-07",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-03-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-07-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-07-09",
            "studyFirstSubmitQcDate": "2024-07-09",
            "studyFirstPostDateStruct": {
                "date": "2024-07-16",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-09",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-16",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Samantha Bento",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "Dana-Farber Cancer Institute"
            },
            "leadSponsor": {
                "name": "Dana-Farber Cancer Institute",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This research study is being done to test the feasibility of an existing supportive program (PRISM) to address psychological symptoms (i.e., depressive and anxiety symptoms) that young adult participants diagnosed with cancer may experience.\n\nThe name of the intervention used in this research study is:\n\n-Promoting Resilience in Stress Management (PRISM) Program",
            "detailedDescription": "This research study is being done to test the initial feasibility and acceptability of a six-session, skills-based resilience coaching intervention, Promoting Resilience in Stress Management (PRISM; Rosenberg et al., 2018; Rosenberg et al., 2021), that targets four resilience resources (stress management, goal setting, cognitive reframing, and meaning-making) for young adult patients (18-25 years old) with nonmetastatic cancer who report moderate depressive and/or anxiety symptoms.\n\nThe research study procedures include screening for eligibility, completing one diagnostic assessment of depressive and anxiety symptoms, pre-intervention and post-intervention questionnaires, completion of the six-session PRISM intervention, and a semi-structured exit interview about the experience with the PRISM intervention.\n\nParticipation in this research study is expected to last approximately 2 to 3 months.\n\nIt is expected that up to 15 young adults with cancer (i.e., participants) and up to a total of 15 support persons (i.e., friends or family members who participants will have an option to invite for the final session of the intervention) will take part in this research study.\n\nThe Hans and Mavis Lopater Foundation is funding this research study by providing philanthropic support."
        },
        "conditionsModule": {
            "conditions": [
                "Cancer Diagnosis",
                "Non-Metastatic Neoplasm",
                "Anxiety",
                "Anxiety Disorders",
                "Depression",
                "Depressive Disorder",
                "Depression, Anxiety"
            ],
            "keywords": [
                "Cancer Diagnosis",
                "Non-Metastatic Neoplasm",
                "Anxiety",
                "Anxiety Disorders",
                "Depression",
                "Depression Disorder",
                "Depression, Anxiety",
                "Young adults with cancer"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 15,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "PRISM Program",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will be enrolled and will complete study procedures as follows:\n\n* Baseline visit with questionnaires.\n* 6 weekly or bi-weekly remote or in-clinic, psychotherapy sessions with psychologist.\n* Final questionnaires and post-study exit interview",
                    "interventionNames": [
                        "Behavioral: Promoting Resilience in Stress Management Program"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "Promoting Resilience in Stress Management Program",
                    "description": "Promoting Resilience in Stress Management (PRISM; Rosenberg et al., 2018; Rosenberg et al., 2021) is is an evidence-based skills-based resilience intervention. In the current study, PRISM sessions with be facilitated by a trained mental health provider to equip participants with skills for coping with anxiety, low mood, and adjustment to cancer diagnosis and to target four resilience resources (i.e., stress management, goal setting, cognitive reframing, and meaning-making). Sessions will be conducted by phone or Zoom, a HIPAA-compliant telemedicine platform. The optional mPRISM phone application includes 6 modules to practice PRISM skills and is available for iOS/Android.",
                    "armGroupLabels": [
                        "PRISM Program"
                    ],
                    "otherNames": [
                        "PRISM Program"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Rate of PRISM Intervention Completion",
                    "description": "Feasibility is defined as 70% of PRISM sessions are completed by participants who start the study.",
                    "timeFrame": "Up to 12 weeks"
                },
                {
                    "measure": "Rate of Study Assessment Completion",
                    "description": "Study feasibility is defined as 70% of all study assessments are completed by participants who complete PRISM sessions.",
                    "timeFrame": "Up to 12 weeks"
                },
                {
                    "measure": "Participant Satisfaction",
                    "description": "Acceptability of the PRISM intervention will be determined by responses on semi-structured exit interviews using descriptive statistics and scores on the Client Satisfaction Questionnaire- (CSQ-8), an 8-item measuring a participant's opinions and assessment of the intervention. Total scores range from 8 to 32 with a higher number indicating greater satisfaction.",
                    "timeFrame": "At final intervention session, up to 6 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "mPRISM Phone Application Usage",
                    "description": "The feasibility of the mPRISM phone application as a tool to practice PRISM skills, as evidenced by the participant usage metrics.",
                    "timeFrame": "Up to 12 weeks"
                },
                {
                    "measure": "Questionnaires",
                    "description": "The feasibility of using the assessment questionnaires in the current study (e.g., length, administration)",
                    "timeFrame": "Up to 12 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria for Participants:\n\n* 18-25 years of age\n* Speak and comprehend English sufficiently to be able to complete study procedures and participate in the program in English\n* Have been diagnosed with nonmetastatic cancer at least 6 or more weeks ago\n* Currently receiving treatment for their cancer or has completed treatment for cancer no more than 6 months ago\n* Score 10-14 on the PHQ-9 (Kroenke et al., 1999) or/and score 10-14 on the GAD-7 (Spitzer et al., 2006) during the initial screening assessment.\n\nParticipant Exclusion Criteria:\n\n* Adults unable to consent, individuals who are not yet adults (age \\<18), pregnant women, and prisoners.\n* Individuals who score \\<10 on both PHQ-9 and GAD-7.\n* Patients who score \\>14 (indicating moderately severe or severe depressive and/or anxiety symptoms) on PHQ-9 and/or GAD-7 will be ineligible for the current study but will be offered a referral to an appropriate mental health provider for support, if desired.\n* Individuals who are diagnosed with a metastatic disease, those who are diagnosed with cancer less than 6 weeks at the time of screening (we will be able to approach them again after 6 weeks since diagnosis has passed), or those who completed cancer treatment more than 6 months ago will also be ineligible for this study; they will be offered resources for support, if desired.\n* Individuals who report any suicidality (ideation, plan, and/or intent) at the time of the eligibility screening will also be excluded from the current study, and the appropriate safety measures and/or referral to a mental health provider will be made.\n\nInclusion Criteria for Support Person:\n\n-\u2265 18 years of age\n\n-A friend or family member invited by the study participant to join the 6th PRISM session",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "25 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Samantha Bento, PhD",
                    "role": "CONTACT",
                    "phone": "617-632-3041",
                    "email": "samanthap_bento@dfci.harvard.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Samantha Bento, PhD",
                    "affiliation": "Dana-Farber Cancer Institute",
                    "role": "PRINCIPAL_INVESTIGATOR"
                },
                {
                    "name": "Greta Jankauskaite, PhD",
                    "affiliation": "Dana-Farber Cancer Institute",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Dana-Farber Cancer Institute",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02215",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Samantha Bento, PhD",
                            "role": "CONTACT",
                            "phone": "617-632-3041",
                            "email": "samanthap_bento@dfci.harvard.ed"
                        },
                        {
                            "name": "Samantha Bento, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "30230531",
                    "type": "BACKGROUND",
                    "citation": "Rosenberg AR, Bradford MC, McCauley E, Curtis JR, Wolfe J, Baker KS, Yi-Frazier JP. Promoting resilience in adolescents and young adults with cancer: Results from the PRISM randomized controlled trial. Cancer. 2018 Oct 1;124(19):3909-3917. doi: 10.1002/cncr.31666. Epub 2018 Sep 19."
                },
                {
                    "pmid": "34817581",
                    "type": "BACKGROUND",
                    "citation": "Rosenberg AR, Zhou C, Bradford MC, Salsman JM, Sexton K, O'Daffer A, Yi-Frazier JP. Assessment of the Promoting Resilience in Stress Management Intervention for Adolescent and Young Adult Survivors of Cancer at 2 Years: Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2021 Nov 1;4(11):e2136039. doi: 10.1001/jamanetworkopen.2021.36039."
                },
                {
                    "pmid": "10259963",
                    "type": "BACKGROUND",
                    "citation": "Attkisson CC, Zwick R. The client satisfaction questionnaire. Psychometric properties and correlations with service utilization and psychotherapy outcome. Eval Program Plann. 1982;5(3):233-7. doi: 10.1016/0149-7189(82)90074-x."
                },
                {
                    "pmid": "16717171",
                    "type": "BACKGROUND",
                    "citation": "Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7. doi: 10.1001/archinte.166.10.1092."
                },
                {
                    "type": "BACKGROUND",
                    "citation": "Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (1999). Patient Health Questionnaire-9 (PHQ-9) [Database record]. APA PsycTests. https://doi.org/10.1037/t06165-000"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "The Dana-Farber / Harvard Cancer Center encourages and supports the responsible and ethical sharing of data from clinical trials. De-identified participant data from the final research dataset used in the published manuscript may only be shared under the terms of a Data Use Agreement. Requests may be directed to: \\[contact information for Sponsor Investigator or designee\\]. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP"
            ],
            "timeFrame": "Data can be shared no earlier than 1 year following the date of publication",
            "accessCriteria": "Contact the Belfer Office for Dana-Farber Innovations (BODFI) at innovation@dfci.harvard.edu"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003863",
                    "term": "Depression"
                },
                {
                    "id": "D000003866",
                    "term": "Depressive Disorder"
                },
                {
                    "id": "D000001008",
                    "term": "Anxiety Disorders"
                }
            ],
            "ancestors": [
                {
                    "id": "D000001526",
                    "term": "Behavioral Symptoms"
                },
                {
                    "id": "D000019964",
                    "term": "Mood Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7058",
                    "name": "Depression",
                    "asFound": "Depression",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7061",
                    "name": "Depressive Disorder",
                    "asFound": "Depression",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4324",
                    "name": "Anxiety Disorders",
                    "asFound": "Anxiety",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4818",
                    "name": "Behavioral Symptoms",
                    "relevance": "LOW"
                },
                {
                    "id": "M21835",
                    "name": "Mood Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}